Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer

Papillary thyroid cancer (PTC) accounts for about 90% of thyroid cancer. There are approximately 20%–30% of PTC patients showing disease persistence/recurrence and resistance to radioactive iodine (RAI) treatment. For these PTC patients with RAI refractoriness, the prognosis is poor. In this study,...

Full description

Bibliographic Details
Main Authors: Lina Liu, Yuhong Shi, Qian Lai, Yuan Huang, Xue Jiang, Qian Liu, Ying Huang, Yuxiao Xia, Dongkun Xu, Zhiqiang Jiang, Wenling Tu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Endocrinology
Subjects:
papillary thyroid cancer
radioactive iodine refractory
RNA signature
prognosis
model
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.865909/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.865909/full

Similar Items